arXiv Science⌕ Search

arXiv subjects

Robert Mikulik

Publications and source records attributed to Robert Mikulik.

2 recordsLinked to original sources

Reaching the last mile? How Design Decisions Shape Medical Device Qualification and Classification of Patient Support Chatbots in the EU

Few AI chatbots have transitioned the 'last mile' from research prototypes to clinical practice, partly because mapping conversational design decisions to regulatory requirements is complicated. This paper presents a design-oriented regulatory analysis of a chatbot supporting stroke survivors. Using Design Space Analysis operationalised through the QOC (Questions, Options, Criteria) framework, HCI researchers and legal scholars assess how variations in three conversational functions - health Q\&A, recovery monitoring, and motivating medical adherence - influence qualification and classification under the European Medical Device Regulation (MDR), General Data Protection Regulation (GDPR), and AI Act (AIA). Our findings show that seemingly minor design decisions - such as role, actionability, and proactivity - influence regulatory obligations. The paper contributes insights into ten conversational design considerations influencing regulatory interpretation and demonstrates how QOC can support integrating legal considerations into human-centred design workflows. Finally, we suggest compliance-aware pathways to market, while reflecting on whether all chatbots should pursue the 'last mile'.

cs.HC↗

From Continuous Predictors to Clinical Thresholds: Early Evidence on Performance Trade-offs of Guideline-Based Categorisation for Ischaemic Stroke Outcome Prediction

Machine learning models achieve strong predictive accuracy for 90-day outcome prediction in acute ischaemic stroke, yet clinical adoption is limited by the misalignment of model explanations with clinicians' reasoning. Motivated by a clinician user study calling for clinical guideline-aligned cut-offs, we ask whether continuous predictors can be replaced by clinically informed categorical encodings without sacrificing performance. On a multi-centre European registry stratified into three treatment cohorts, we compare standard and fully categorised gradient-boosted models, the latter using stroke guideline-aligned, treatment-specific thresholds. The fully categorised models are statistically indistinguishable from their continuous counterparts in two of the treatment cohorts, with a significant drop in predictive accuracy in one cohort. Global feature importance rankings remain consistent, suggesting that discretising continuous predictors into guideline-based categories preserves the core hierarchy of prognostic factors across all treatment groups. Guideline-based categorisation is thus a viable design choice for stroke-outcome models.

cs.AI↗